The Prediction of Atherosclerotic Cardiovascular Disease in Type 1 Diabetes: Do We Just Stop Here?
Type 1 diabetes (T1D) is well recognized to be associated with a higher incidence and prevalence of atherosclerotic cardiovascular disease (ASCVD)1. However, randomized clinical trials in which risk factors for ASCVD (blood pressure, lipids, glycemia) have been modified are non-existent for T1D patients. Thus, any model that is developed must be based on observational data only. The Steno Risk Engine as described in this issue of Circulation2 is the second attempt at estimating ASCVD risk in T1D patients and differs somewhat in design and application from that previously created from the Swedish National Diabetes Register (NDR).3
- Received February 16, 2016.
- Accepted February 16, 2016.